These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26386298)

  • 1. Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies.
    Petta S; Maida M; Macaluso FS; Barbara M; Licata A; Craxì A; Cammà C
    Gastroenterology; 2016 Jan; 150(1):145-155.e4; quiz e15-6. PubMed ID: 26386298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C and Its Metabolic Complications in Kidney Disease.
    Fabrizi F; Donato FM; Messa P
    Ann Hepatol; 2017 November-December,; 16(6):851-861. PubMed ID: 29055921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
    Mitwalli AH; Hayat A; Alwakeel J; Hammad D
    Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis.
    Chen Y; Ji H; Shao J; Jia Y; Bao Q; Zhu J; Zhang L; Shen Y
    Dig Dis Sci; 2020 Jul; 65(7):1940-1950. PubMed ID: 31758432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis.
    Su X; Zhao X; Deng JL; Li SN; Du X; Dong JZ; Ma CS
    J Viral Hepat; 2021 Apr; 28(4):664-671. PubMed ID: 33452699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study.
    Coppo C; Bonfanti D; Bo S; Giordanino C; Gallo M; Cococcia S; Ciccone G; Smedile A; Ciancio A; Bugianesi E; Fagoonee S; Pellicano R; Rizzetto M; Saracco GM
    Dig Liver Dis; 2015 May; 47(5):405-10. PubMed ID: 25733341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis.
    Feng B; Eknoyan G; Guo ZS; Jadoul M; Rao HY; Zhang W; Wei L
    Nephrol Dial Transplant; 2012 Feb; 27(2):640-6. PubMed ID: 21558431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.
    Mühlberger N; Schwarzer R; Lettmeier B; Sroczynski G; Zeuzem S; Siebert U
    BMC Public Health; 2009 Jan; 9():34. PubMed ID: 19161623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
    Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of HCV infection in the general population: a survey in a southern Italian town.
    Cozzolongo R; Osella AR; Elba S; Petruzzi J; Buongiorno G; Giannuzzi V; Leone G; Bonfiglio C; Lanzilotta E; Manghisi OG; Leandro G; ; Donnaloia R; Fanelli V; Mirizzi F; Parziale L; Crupi G; Detomaso P; Labbate A; Zizzari S; Depalma M; Polignano A; Lopinto D; Daprile G
    Am J Gastroenterol; 2009 Nov; 104(11):2740-6. PubMed ID: 19638964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection.
    Park H; Adeyemi A; Henry L; Stepanova M; Younossi Z
    J Viral Hepat; 2015 Nov; 22(11):897-905. PubMed ID: 25904153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus.
    Arao M; Murase K; Kusakabe A; Yoshioka K; Fukuzawa Y; Ishikawa T; Tagaya T; Yamanouchi K; Ichimiya H; Sameshima Y; Kakumu S
    J Gastroenterol; 2003; 38(4):355-60. PubMed ID: 12743775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
    Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK
    Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes.
    Sasso FC; Pafundi PC; Caturano A; Galiero R; Vetrano E; Nevola R; Petta S; Fracanzani AL; Coppola C; Di Marco V; Solano A; Lombardi R; Giordano M; Craxi A; Perrella A; Sardu C; Marfella R; Salvatore T; Adinolfi LE; Rinaldi L
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2345-2353. PubMed ID: 34053830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.
    Innes HA; McDonald SA; Dillon JF; Allen S; Hayes PC; Goldberg D; Mills PR; Barclay ST; Wilks D; Valerio H; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley AJ; Bramley P; Hutchinson SJ
    Hepatology; 2015 Aug; 62(2):355-64. PubMed ID: 25716707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.